Does ILOPROST TROMETHAMINE Cause Systemic scleroderma? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Systemic scleroderma have been filed in association with ILOPROST TROMETHAMINE. This represents 7.0% of all adverse event reports for ILOPROST TROMETHAMINE.
5
Reports of Systemic scleroderma with ILOPROST TROMETHAMINE
7.0%
of all ILOPROST TROMETHAMINE reports
5
Deaths
5
Hospitalizations
How Dangerous Is Systemic scleroderma From ILOPROST TROMETHAMINE?
Of the 5 reports, 5 (100.0%) resulted in death, 5 (100.0%) required hospitalization.
Is Systemic scleroderma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ILOPROST TROMETHAMINE. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does ILOPROST TROMETHAMINE Cause?
Off label use (11)
Right ventricular failure (11)
Encephalopathy (8)
Congestive cardiomyopathy (7)
Disease progression (7)
Sepsis (7)
Drug ineffective (6)
Pneumonia (6)
Cardiac dysfunction (5)
Galectin-3 increased (5)
What Other Drugs Cause Systemic scleroderma?
RITUXIMAB (54)
CYCLOPHOSPHAMIDE (53)
MACITENTAN (52)
DOCETAXEL (49)
METHOTREXATE (45)
MYCOPHENOLATE MOFETIL (44)
FLUOROURACIL (34)
SELEXIPAG (34)
TREPROSTINIL (34)
BOSENTAN (30)